(1) A licensee shall control access to the
treatment room by a door at each entrance.
(2) A licensee shall equip each entrance to
the treatment room with an electrical interlock system that shall:
(a) Prevent the operator from initiating the
treatment cycle unless each treatment room entrance door is closed;
(b) Cause the source(s) to be shielded when
an entrance door is opened; and,
(c) Prevent the source(s) from being exposed
following an interlock interruption until all treatment room entrance doors are
closed and the source(s) on-off control is reset at the
console.
(3) A licensee
shall require any individual entering the treatment room to assure, through the
use of appropriate radiation monitors, that radiation levels have returned to
ambient levels.
(4) Except for
low-dose remote afterloader units, a licensee shall construct or equip each
treatment room with viewing and intercom systems to permit continuous
observation of the patient or the human research subject from the treatment
console during irradiation.
(5) For
licensed activities where sources are placed within the patient's or human
research subject's body, a licensee shall only conduct treatments which allow
for expeditious removal of a decoupled or jammed source.
(6) In addition to the requirements specified
in subsections
64E-5.637(1) through
(5), F.A.C., of this section, a licensee
shall:
(a) For medium dose-rate and pulsed
dose-rate remote afterloader units, require:
1. An authorized medical physicist and
either, an authorized user or a physician, under the supervision of an
authorized user, who have been trained in the operation and emergency response
for the unit, to be physically present during the initiation of all patient
treatments involving the unit; and,
2. An authorized medical physicist and
either, an authorized user or an individual under, the supervision of an
authorized user, who have been trained to remove the source applicator(s) in
the event of an emergency involving the unit, to be immediately available
during continuation of all patient treatments involving the
unit.
(b) For high
dose-rate remote afterloader units, require:
1. An authorized user and an authorized
medical physicist to be physically present during the initiation of all patient
treatments involving the unit; and,
2. An authorized medical physicist and
either, an authorized user or a physician, under the supervision of an
authorized user, who have been trained in the operation and emergency response
for the unit, to be physically present during continuation of all patient
treatments involving the unit.
(c) For gamma stereotactic radiosurgery
units, require an authorized user and an authorized medical physicist to be
physically present throughout all patient treatments involving the
unit.
(d) Notify the RSO, or
his/her designee, and an authorized user as soon as possible if the patient or
human research subject has a medical emergency or dies.
(7) A licensee shall have applicable
emergency response equipment available near each treatment room in order to
respond to a source remaining in the unshielded position or lodged within the
patient following completion of the treatment.